NCT04709172View on ClinicalTrials.gov

Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 5, 2021

Primary Completion Date

August 15, 2021

Study Completion Date

August 15, 2021

Conditions
COVID-19 Pneumonia
Interventions
DRUG

Cefditoren pivoxil 400mg

Cefditoren pivoxil 400mg bid for 7 days

Trial Locations (1)

28822

HU Henares, Coslada

Sponsors
All Listed Sponsors
lead

Meiji Pharma Spain S.A.

INDUSTRY